Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Akebia Therapeutics Inc. sell Global_Player

Akebia Therapeutics Inc.
Start price
€1.44
23.05.23 / 50%
Target price
-
23.05.24
Performance (%)
-21.56%
End price
€1.13
25.05.23
Summary
This prediction ended on 25.05.23 with a price of €1.13. The prediction for Akebia Therapeutics Inc. closed with a convincing performance of -21.56%. Global_Player has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Akebia Therapeutics Inc. 0.164% 0.164% -73.623% -36.632%
iShares Core DAX® -0,05 % 5,96 % 7,40 % 65,85 %
iShares Nasdaq 100 0,92 % 3,69 % 28,14 % 93,30 %
iShares Nikkei 225® 3,01 % 6,64 % 48,89 % 89,08 %
iShares S&P 500 -0,36 % 2,75 % 22,53 % 71,94 %

According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Global_Player for this prediction

In the thread Akebia Therapeutics Inc. diskutieren

Sell Akebia Therapeutics Inc.

Global_Player 
0
Report Share
23.05.23 Sell -21.56%
In the thread Trading Akebia Therapeutics Inc.
Prediction Sell
Perf. (%) -21.56%
Target price
Change
Ends at 23.05.24

Sell beendet

Global_Player 
0
Report Share
25.05.23